[no definition available]
| Timeframe | Studies on this Protein(%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0) | 18.7374 |
| 1990's | 0 (0) | 18.2507 |
| 2000's | 0 (0) | 29.6817 |
| 2010's | 0 (0) | 24.3611 |
| 2020's | 0 (0) | 2.80 |
| Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
|---|---|---|---|---|---|
| unden | Homo sapiens (human) | AC50 | 70.0000 | 1 | 0 |
| syrosingopine | Homo sapiens (human) | AC50 | 27.2900 | 1 | 0 |
| raloxifene hydrochloride | Homo sapiens (human) | AC50 | 45.2600 | 1 | 0 |
| 6-ketoestradiol | Homo sapiens (human) | AC50 | 70.0000 | 1 | 0 |
| equilin | Homo sapiens (human) | AC50 | 70.0000 | 1 | 0 |
| neoastilbin | Homo sapiens (human) | AC50 | 10.2200 | 2 | 0 |
| likviriton | Homo sapiens (human) | AC50 | 15.5800 | 2 | 0 |
| 4-[[[2-(3-methylphenyl)ethylamino]-sulfanylidenemethyl]amino]benzoic acid methyl ester | Homo sapiens (human) | AC50 | 70.0000 | 1 | 0 |
| N-(1,3-benzothiazol-2-yl)-3-(2,3-dihydroindol-1-ylsulfonyl)benzamide | Homo sapiens (human) | AC50 | 70.0000 | 1 | 0 |
| 5-(2-nitrophenyl)-N-(2-thiazolyl)-2-furancarboxamide | Homo sapiens (human) | AC50 | 70.0000 | 1 | 0 |
| 2-chloro-N-(2-methyl-6-oxo-5H-benzo[b][1,4]benzoxazepin-8-yl)acetamide | Homo sapiens (human) | AC50 | 8.5100 | 1 | 0 |
| Anthraniloyllycoctonine | Homo sapiens (human) | AC50 | 19.5000 | 2 | 0 |
| quercitrin | Homo sapiens (human) | AC50 | 2.4800 | 2 | 0 |
| myricitrin | Homo sapiens (human) | AC50 | 9.8000 | 2 | 0 |
| astragalin | Homo sapiens (human) | AC50 | 19.0200 | 2 | 0 |
| kaempferol 3-O-beta-L-glucopyranoside | Homo sapiens (human) | AC50 | 0.0155 | 2 | 0 |
| N-[(2R,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methyl-3-indolyl)acetamide | Homo sapiens (human) | AC50 | 8.8100 | 2 | 0 |